Chang‐Jun Tan

932 total citations · 1 hit paper
28 papers, 706 citations indexed

About

Chang‐Jun Tan is a scholar working on Hepatology, Oncology and Molecular Biology. According to data from OpenAlex, Chang‐Jun Tan has authored 28 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Chang‐Jun Tan's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Liver physiology and pathology (4 papers). Chang‐Jun Tan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Liver physiology and pathology (4 papers). Chang‐Jun Tan collaborates with scholars based in China, Norway and Germany. Chang‐Jun Tan's co-authors include Jia Fan, Jian Zhou, Jian Zhou, Ying‐Hao Shen, Hui‐Chuan Sun, Cheng Huang, Xiao‐Dong Zhu, Ningling Ge, Zhao–You Tang and Yuan Ji and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chang‐Jun Tan

26 papers receiving 698 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

2021 159 citations Xiao‐Dong Zhu, Cheng Huang et al. Liver Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chang‐Jun Tan China	14	338	224	180	168	166	28	706
Kathryn Effendi Japan	16	260 0.8×	359 1.6×	232 1.3×	198 1.2×	76 0.5×	23	766
M. Wu China	11	298 0.9×	377 1.7×	183 1.0×	279 1.7×	224 1.3×	24	872
Emanuela Balladore Italy	8	160 0.5×	272 1.2×	405 2.3×	132 0.8×	88 0.5×	14	771
Deborah Lehrer United States	11	365 1.1×	210 0.9×	240 1.3×	128 0.8×	49 0.3×	21	706
Qiong Xue China	13	207 0.6×	451 2.0×	258 1.4×	309 1.8×	48 0.3×	22	872
Valeria Iansante United Kingdom	10	196 0.6×	325 1.5×	163 0.9×	110 0.7×	206 1.2×	16	664
Matthias Van Haele Belgium	12	115 0.3×	241 1.1×	106 0.6×	100 0.6×	81 0.5×	15	460
Shin-ichi Aishima Japan	17	168 0.5×	489 2.2×	445 2.5×	150 0.9×	498 3.0×	20	1.1k
Feiguo Zhou China	11	191 0.6×	266 1.2×	126 0.7×	180 1.1×	43 0.3×	18	575
Jacinth Wing‐Sum Cheu Hong Kong	10	133 0.4×	383 1.7×	296 1.6×	287 1.7×	54 0.3×	14	829

Countries citing papers authored by Chang‐Jun Tan

Since Specialization

Citations

This map shows the geographic impact of Chang‐Jun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Jun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Jun Tan more than expected).

Fields of papers citing papers by Chang‐Jun Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Jun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Jun Tan. The network helps show where Chang‐Jun Tan may publish in the future.

Co-authorship network of co-authors of Chang‐Jun Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Jun Tan. A scholar is included among the top collaborators of Chang‐Jun Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Jun Tan. Chang‐Jun Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Yi-Min, Hui Shen, Guo‐Huan Yang, et al.. (2025). Cordycepin mediates pyroptosis in HCC through the upregulation of TXNIP and synergizes with anti–PD-L1 immunotherapy. Hepatology Communications. 9(3). 1 indexed citations

Tan, Chang‐Jun, et al.. (2024). Chailing Decoction Generated Foxp3+ Regulatory T Cells and Suppressed Activity of mTOR Signaling Pathway in a Murine Cardiac Transplantation Model. 3(5). 1 indexed citations

Sun, Hui‐Chuan, Ying‐Hao Shen, Xiao‐Dong Zhu, et al.. (2023). The development and prospects of liver surgery. SHILAP Revista de lepidopterología. 2(1). 100009–100009.

Xu, Minghao, Cheng Huang, Xiao‐Dong Zhu, et al.. (2023). Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A real‐world cohort study. Cancer Medicine. 12(8). 9202–9212. 8 indexed citations

Huang, Cheng, Xiao‐Dong Zhu, Ying‐Hao Shen, et al.. (2021). Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis. Biomarker Research. 9(1). 19–19. 48 indexed citations

Zhu, Xiao‐Dong, Cheng Huang, Ying‐Hao Shen, et al.. (2021). Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations. Liver Cancer. 10(4). 320–329. 159 indexed citations breakdown →

Tan, Chang‐Jun, et al.. (2018). An alternative technique of arterial anastomosis in mouse heart transplantation. Clinical Transplantation. 32(6). e13264–e13264. 1 indexed citations

Yan, Jun, Zhichao Fan, Xiufeng Wu, et al.. (2015). Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model. Cytometry Part A. 87(11). 1020–1028. 28 indexed citations

Xu, Min, Chang‐Jun Tan, Jinwu Hu, et al.. (2014). Expression of Hemopexin in Acute Rejection of Rat Liver Allograft Identified by Serum Proteomic Analysis. Shock. 42(1). 65–74. 5 indexed citations

10.

Sun, Qi‐Man, Chang‐Jun Tan, Min Xu, et al.. (2014). Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF-1α expression in vivo. Molecular Medicine Reports. 10(2). 585–592. 8 indexed citations

11.

Hu, Jie, Zheng Wang, Chang‐Jun Tan, et al.. (2013). Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation. Transplantation. 95(8). 991–999. 58 indexed citations

12.

Yan, Jun, Chang‐Jun Tan, Fangming Gu, et al.. (2013). Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase. Liver Transplantation. 19(5). 507–520. 18 indexed citations

13.

Li, Quan‐Lin, Fangming Gu, Zheng Wang, et al.. (2012). Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma. PLoS ONE. 7(3). e33379–e33379. 50 indexed citations

14.

Wang, Zheng, Jie Hu, Shuang–Jian Qiu, et al.. (2011). An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels. Expert Opinion on Investigational Drugs. 20(8). 1039–1045. 11 indexed citations

15.

Xu, Min, Chang‐Jun Tan, Jian Zhou, et al.. (2009). The dynamic changes of T-bet+/GATA-3+ and RORγt+/FOXP3+ cells in recipient spleens and grafts after rat orthotopic liver transplantation. Transplant Immunology. 22(3-4). 165–171. 7 indexed citations

16.

Wang, Zheng, Jian Zhou, Jia Fan, et al.. (2009). Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opinion on Investigational Drugs. 18(11). 1595–1604. 21 indexed citations

17.

Guo, Weigang, et al.. (2008). Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats. Critical Care Medicine. 36(4). 1205–1213. 30 indexed citations

18.

Wang, Zheng, Jian Zhou, Jia Fan, et al.. (2008). Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 135(5). 715–722. 46 indexed citations

19.

Dai, Zhi, Jia Fan, Yinkun Liu, et al.. (2007). Identification and analysis of α1,6‐fucosylated proteins in human normal liver tissues by a target glycoproteomic approach. Electrophoresis. 28(23). 4382–4391. 20 indexed citations

20.

Zhou, Jian, Zhao–You Tang, Zhi-Quan Wu, et al.. (2006). Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.. PubMed. 53(68). 275–80. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact